Some authors have suggested that the carcinogenic effect of radon may be potentiated by the accumulation of hereditary polymorphisms in GSTM1/GSTT1, mutations in tumours suppressor genes such as TP53 and germline pathogenic alterations in HRR genes [52,53,54,55]. The gene discussed is TP53; the disease is neoplasm.